Today Merck announced the decision to discontinue supplying the continuous release (CR) formulation of SINEMET® in the U.S. Sinemet® is the brand name formulation of carbidopa/levodopa. SINEMET CR will continue to be available until the current inventory is depleted.
NEW YORK & MIAMI — July 16, 2019 — The Parkinson’s Foundation is pleased to announce the launch of PD GENEration: Mapping the Future of Parkinson’s Disease, a first-of-its-kind national initiative that offers free genetic testing for clinically relevant Parkinson’s-related genes and free genetic counseling to help participants better understand
NEW YORK & MIAMI — July 8, 2019 — The Parkinson’s Foundation today announced that it has awarded its second Parkinson’s Foundation Nurse Faculty Award to three nurses, totaling $30,000. The nurses, all graduates of the Edmond J.
— Total Cost of Parkinson’s Disease to Individuals, Families and the U.S. Government Nearly $52 Billion Each Year —
Parkinson’s Foundation staff presents ten groundbreaking research programs at the conference in Kyoto, Japan
Partnership with The Medical University of South Carolina
Honoring Nurse Appreciation Week, the course aims to help people with Parkinson’s live better
NEW YORK & MIAMI — MAY 8, 2019 — The Parkinson’s Foundation announced the appointment of Ponder Harrison, senior advisor at Comvest Partners and Franklin Resources’ Industrial Technology Fund, to its board of directors.
NEW YORK & MIAMI – April 22, 2019 – The Parkinson’s Foundation today announced the recipients of more than $1.5 million in community grants for Parkinson’s programs. Community grants support local health, wellness and educational programs that address unmet needs in the Parkinson’s disease (PD) community.
MIAMI & NEW YORK — March 25, 2019 — Recognizing long-standing gender disparities in Parkinson’s research and care, the Parkinson’s Foundation Women and Parkinson’s Initiative has created the first patient-centered action agenda to maximize quality of life for women with Parkinson’s disease.